Magnetic resonance imaging for lung scarring
This study uses a special type of MRI scan to see how well treatment for lung scarring (pulmonary fibrosis) is working. It may help doctors understand if the medication you're taking is helping your lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with fibrotic interstitial lung disease and are eligible for antifibrotic medication.
- You can have an MRI and CT scan safely (no metal implants, no severe claustrophobia).
- You are not pregnant or breastfeeding.
- You can hold your breath for the scans and perform breathing tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special MRI and CT scans to take very detailed pictures of the lungs in people with mild asthma. The goal is to learn more about how asthma affects the lungs, which could help develop better treatments.
This study tests whether a special MRI scan using xenon gas can be done safely and provide useful information in people with chronic lung conditions. You may be able to take part if your breathing tests and oxygen levels are adequate and you can complete the MRI safely.
This study tests whether advanced MRI scans can better detect and track lung scarring in people with certain types of pulmonary fibrosis. It may help doctors understand how well your treatment is working, without extra radiation from CT scans.
This trial uses an advanced MRI technique with a special gas (hyperpolarized xenon-129) to look at lung function in people with idiopathic pulmonary fibrosis (IPF). It may help doctors better understand how the disease affects your lungs and could lead to improved care.
This study uses MRI scans to monitor how lung scarring changes over time in people with certain types of interstitial lung disease (ILD), like idiopathic pulmonary fibrosis (IPF). The goal is to see if MRI can be a helpful tool for tracking the disease without needing as many CT scans.
This study uses MRI scans to look at the lungs of people with early-stage IPF, a lung scarring disease. It aims to see how well MRI can show lung changes without using radiation.
Hear when a new Fibrotic Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.